1. Field of Invention
The invention relates to a open ended elasticized device, tubular in shape, designed to compress, encompass, protect, retain, site and or deliver medication to an extremity or thorax of a human or animal.
2. Description of Prior Art
There have been many previous devices for the protection of extremities, appendages or thorax for humans or animals in protecting articles and site from contamination or for preventing water, dirt or hazardous articles from contaminating the site. The suggestion of a single closed-ended bag, glove like device and open-ended tubular device with sealable or elasticized ends presently exists with all of the following U.S. Pat. Nos. 5,357,633, 5,187,813, 5,063,919, 5,016,648, 4,991,593, 4,971,233, 4,926,851, 4,856,112, 4,646,727, 4,315,504, 4,287,608, 4,133,624, 4,016,027, 2,704,069, 2,169,203, 5,592,953, 5,228,851, 5,143,762, 3,416,518. Each of the prior art products although being able to protect extremities from contamination are flawed and limited in their design. The various prior art configurations do nothing to fully compress the site. Compression of the medical site is required to facilitate holding an Intra Venous item, compressing the wound in the event of bleeding, delivery of medication via impregnation to the I.V. Sleeve itself. Compression throughout the entire extremity, thorax and site is as well required in the event of product failure. On all prior art, failure of an elasticized end or puncture to the product would render such product inoperable and useless. The I.V. Sleeve is designed to maintain its integrity even in the event of a tear or puncture.
In addition the I.V. Sleeve is designed to facilitate the manufacturing and field use process by using a simple pre-existing and time proven manufacturing process that not only pre packages and protects the I.V. Sleeve from contamination, but allows it to be carried in to the field in a disposable pack like that of a Handy-Wipe or condom.
Prior art product have as well failed to maintain pace with modern medicine. All prior art fails to deliver medication to the site. The I.V. Sleeves ability to fit skin tight and its ability to be manufactured using a vast number or different materials allows it to be impregnated with medication so that such medication can be delivered through skin absorption. Unlike prior art product the I.V. Sleeve's ability to be manufactured from skin type products allows for exceptional seamless coverage and medication in the event of skin grafts required for large areas.
The object of the invention is to have field usable cost effective product that can fully protect an extremity, appendage and thorax during pre and post medical procedures. The I.V. Sleeve is used for humans and animals. It compresses the entire wound or medical site to maintain the integrity of the procedure and to deliver medication when desired.
The I.V. Sleeve is manufactured with materials that fit the environmental parameters dictated by the wound or medical procedure in itself. In the event of grafts, the I.V. Sleeve is manufactured from skin. It can be waterproof yet breathable and maintains it's anti contaminant integrity even in the event of puncture or tear. Its elasticity allows for ability to protect a human thorax as well as a leg, arm or finger.
The invention relates to a skintight elastic sleeve that is reinforced with elastic bands 8 throughout its entire circumference and length as seen in FIG. 1. To be fitted onto appendages, extremities, neck or thorax for achieving complete site compression, protection, and for maintenance of integrity of a medical site or intravenous equipment 9. Whereas the sleeve body 1 and band 8 are manufactured from a group of elastic, pliable and expendable materials singularly and in combination such as rubber, latex, silicone, Gore-Tex, epidermal tissue, smooth muscle tissue, plastic and plastic components that are capable of expanding to 3 times its original state.
The sleeve is cylindrical in shape with openings at both ends 6 and 7. The body or the sleeve 1 shall be of sufficient thickness to protect the medical site while maintaining sufficient transparency to view such site without the need to remove the sleeve. The bands 8 around the sleeve shall be of identical material used in the manufacturing of the body 1 of the sleeve so to facilitate the manufacturing process. The body 1 of the sleeve and band 8 are of identical diameter and elasticity so as to apply sufficient force for sealing the sleeve end 6 and 7 without inhibiting circulation. Multiple bands 8 are fitted throughout the circumference and entire length of sleeve separated by a distance of 2.54 cm or 1 inch from each other as seen in FIG. 3. As an example: If the length of the sleeve was 25.40 cm or 10 inches then there would be a total of 11 bands. First band 8 would initiate at end 6. The second band would be 2.54 cm or 1 inch from the first and each consecutive band would be 2.54 cm from the previous until the final and eleventh band terminated on end 7. If the length of the sleeve was 20 inches then there would be twice as many bands 8. The bands 8 between the ends 6 and 7 are manufactured by collecting 2 cm of body 1 material around the entire circumference of the sleeve and then folding and adhering the material back onto the body 1 as shown in
U.S. Pat. Documents3416518Dec., 1968Samuels602/3. 5143762Sep., 1992Ho128/846.5228851Jul., 1993Burton604/171.5592953Jan., 1997Delao602/3. 2169203Aug., 1939Hinchliff66/178.2704069Mar., 1955Donelan128/881.4016027Apr., 1977Kintanar 2/159.4133624Jan., 1979Heavner et al.425/275.4287608Sep., 1981Meyer 2/16.4315504Feb., 1982Drennan128/881.4646727Mar., 1987Chambers128/882.4856112Aug., 1989Effle 2/59.4926851May., 1990Bulley128/157.4971233Nov., 1990Keenan223/111.4991593Feb., 1991LeVahn128/856.5016648May., 1991Brown128/879.5063919Nov., 1991Silverberg602/3. 5187813Feb., 1993Klein 2/16.5357633Oct., 1994Rael 2/16.
Number | Name | Date | Kind |
---|---|---|---|
2704069 | Donelan | Mar 1955 | A |
3416518 | Samuels | Dec 1968 | A |
3747374 | Meyer | Jul 1973 | A |
4016027 | Kintanar | Apr 1977 | A |
4133624 | Heavner et al. | Jan 1979 | A |
4287608 | Meyer | Sep 1981 | A |
4315504 | Drennan | Feb 1982 | A |
4470410 | Elliott | Sep 1984 | A |
4646727 | Chambers | Mar 1987 | A |
4856112 | Effle | Aug 1989 | A |
4926851 | Bulley | May 1990 | A |
4971233 | Keenan | Nov 1990 | A |
4991593 | LeVahn | Feb 1991 | A |
5016648 | Brown | May 1991 | A |
5063919 | Silverberg | Nov 1991 | A |
5143762 | Ho | Sep 1992 | A |
5187813 | Klein | Feb 1993 | A |
5228851 | Burton | Jul 1993 | A |
2169203 | Hinchliff | Sep 1993 | A |
5344406 | Spooner | Sep 1994 | A |
5357633 | Rael | Oct 1994 | A |
5592953 | Delao | Jan 1997 | A |
Number | Date | Country | |
---|---|---|---|
20030094179 A1 | May 2003 | US |